UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                                  _____________

                                    Form 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of earliest event reported): January 10, 2007


                              OCEAN BIO-CHEM, INC.
               (Exact name of registrant as specified in charter)

         Florida                       0-11102                   59-1564329
(State or Other Jurisdiction    (Commission File Number)       I.R.S. Employer
     of Incorporation)                                       Identification No.)

               4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
                (Address of principal executive office Zip Code)

                                 (954) 587-6280
               Registrant's telephone number, including area code:

                                 Not Applicable
          (Former name or former address, if changes since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

     [ ] Written  communications  pursuant to Rule 425 under the  Securities Act
(17 CFR 230.425)

     [ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     [ ]  Pre-commencement  communications  pursuant to Rule 14d-2(b)  under the
Exchange Act (17 CFR 240.14d-2(b))

     [ ]  Pre-commencement  communications  pursuant to Rule 13e-4(c)  under the
Exchange Act (17 CFR 240.13e-4(c))




Item 7.01 Regulation FD Disclosure:

     Effective  January 8, 2007 we  commenced  shipping  against  open  Purchase
Orders to Wal-Mart which increases our product  distribution  and the chain-wide
store count of units offering our line. Wal-Mart,  a longstanding  customer will
carry an increased  assortment of our products,  featuring their introduction of
our Fuel Additive,  StarTron  products,  in approximately  2,700 retail outlets,
many of  which  did not  previously  carry  any of our  products.  Our  StarTron
products are gaining national consumer recognition and we expect to aggressively
promote these items during the current year in order to more fully develop their
potential.

     We have modified our short and long term manufacturing  production plans to
include retail "sell-through" projections presented to us by Wal-Mart.  Although
the financial  impact of the expanded  distribution  for the remaining months of
the year ending  December 31, 2007 cannot be  ascertained  at this time, we will
publicly  disclose our progress in this regard in  prospective  filings with the
Commission.


                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                           Ocean Bio-Chem, Inc.


January 10, 2007                           /s/ Peter G. Dornau
                                           -----------------------------
                                           Peter G. Dornau
                                           President and
                                           Chief Executive Officer